Efficacy and effects of trimetazidine + enalapril + metoprolol versus enalapril + metoprolol in very elderly hypertensive patients with chronic heart failure New York Heart Association class II with preserved ejection fraction

Trial Profile

Efficacy and effects of trimetazidine + enalapril + metoprolol versus enalapril + metoprolol in very elderly hypertensive patients with chronic heart failure New York Heart Association class II with preserved ejection fraction

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2013

At a glance

  • Drugs Trimetazidine (Primary) ; Enalapril; Metoprolol
  • Indications Chronic heart failure
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 30 Sep 2013 New trial record
    • 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top